News

Blacks, Hispanics less likely than whites to receive pre-ESRD care


 

References

Black and Hispanic patients with end-stage renal disease caused by lupus nephritis were 27% less likely to receive pre-ESRD care than were their white counterparts, reported Laura C. Plantinga, Ph.D., and her associates at Emory University, Atlanta.

Using data from the United States Renal Data System, the investigators determined that 71.1% out of a total of 6,594 incident LN-ESRD patients who initiated treatment from 2005 to 2011 received pre-ESRD nephrology care. Lack of insurance or being on Medicaid at the start of ESRD start also was associated with inadequate ESRD care, as those with Medicaid or no insurance were 49% and 64% less likely, respectively, than were those with private insurance to be placed on a kidney transplant wait list.

“Our findings also indicate substantial sociodemographic and regional disparities in the translation of quality-of-care measures related to pre-ESRD care, access to transplant, and placement of permanent vascular access among LN-ESRD patients,” the authors wrote.

Read the entire article, published Feb. 25 in Arthritis & Rheumatology (doi:10.1002/art.38983).

Recommended Reading

For lupus nephritis patients, proteinuria is best predictor of renal outcomes
MDedge Rheumatology
High interferon levels related to preeclampsia in pregnant lupus patients
MDedge Rheumatology
Lupus doesn’t predict poor hip or knee arthroplasty outcomes
MDedge Rheumatology
Periostin has potential as biomarker in lupus nephritis
MDedge Rheumatology
Asians, Hispanics fare best with lupus nephritis–linked end-stage renal disease
MDedge Rheumatology
Best triptorelin dose identified for ovarian suppression in adolescents with lupus
MDedge Rheumatology
New concerns rise over iatrogenic hydroxychloroquine retinopathy
MDedge Rheumatology
An expert on primary Raynaud’s phenomenon describes treatment approach
MDedge Rheumatology
How to halt ‘a heart attack of the finger’
MDedge Rheumatology
Differentiating between primary and secondary Raynaud’s
MDedge Rheumatology